TL;DR: India is a major medical-tourism destination, but most hospitals chase international patients with generic "best hospital India" campaigns. Country-specific, channel-specific marketing — paired with a real IPD desk and accreditation — wins the patients that compound.
EDITORIAL · JUN 2026
International Patient Acquisition for Indian Hospitals
By Qlarify Health Team · 12 min read
India receives an estimated 600,000+ international medical travellers a year across the major destination cities — Delhi NCR, Chennai, Bengaluru, Mumbai, Hyderabad, Kochi. The economic value is meaningful, the clinical capability is genuine, and yet most Indian hospitals chasing international patients waste their budget on generic Google Ads campaigns targeting "best hospital India."
Serious IPD growth needs source-segment thinking, country-specific channels, and a real IPD desk function — not a translation of the domestic campaign.
The four source segments
SAARC and South Asia. Bangladesh, Nepal, Sri Lanka, Maldives. Highest volume, lower revenue per case, strong word-of-mouth networks, often paid out-of-pocket.
Africa. Nigeria, Kenya, Tanzania, Ethiopia, Sudan. Significant cardiac, oncology, and complex surgery demand. Patient often travels with family; logistics matter.
GCC and the Middle East. Iraq, Oman, UAE. Higher revenue per case, expectation of premium service standards, often insurance or government referral.
CIS and Southeast Asia. Uzbekistan, Kazakhstan, Myanmar, Vietnam. Growing segments; often facilitator-network driven.
Channel strategy by region
SAARC: WhatsApp-led, patient testimonials in local languages, community-leader endorsement. Africa: facilitator partnerships, embassy referral lists, Africa-specific Google and Meta campaigns with country targeting. GCC: Arabic-language landing pages, premium service positioning, ties with regional health insurers. CIS: agent-network management is half the channel mix.
The IPD desk function
A real IPD desk is more than a translation team. Visa support, airport pickup, hotel coordination, embassy liaison, multi-lingual case coordinators, and post-treatment follow-up that bridges back to the home country. Hospitals that under-staff this function lose to hospitals that treat it as a strategic department.
NABH International, JCI, and pricing transparency
NABH International (NABH's international standards) and JCI accreditation are increasingly expected for serious IPD work. Transparent procedure pricing — published cost bands by procedure on the international microsite — wins trust where opacity loses it. International patients hate price negotiations after arrival.
Should we work with medical-tourism facilitators?
Selectively. Reputable facilitators in specific source countries (Bangladesh, Nigeria, Iraq) genuinely add patient flow. Poor facilitators sell you on volume that doesn't convert. Diligence on referral quality and ethical practices matters.
Do we need JCI accreditation for international patients?
It helps significantly with GCC insurance referrals and corporate-buyer trust. For SAARC and parts of Africa, NABH International or strong specialty accreditation is often sufficient. JCI is a multi-year, multi-crore investment — assess against your source-segment mix.
What's the highest-volume international source country for India?
Bangladesh by patient count, followed by Iraq, Nigeria, Oman, and Maldives. Revenue mix per source country differs — Bangladesh is high-volume but moderate-revenue, GCC and Africa carry higher revenue per case.
How do we handle pricing transparency for international patients?
Publish indicative cost bands by procedure on the international microsite. Pre-arrival written estimates signed off by the IPD desk. Avoid renegotiation after arrival — it is the single biggest source of bad reviews from international cohorts.
Build serious international patient flow.
We design country-specific IPD acquisition programmes for Indian hospitals — SAARC, Africa, GCC, CIS — paired with the desk function that delivers.